IAG Cargo upsizes from A321 to B777 on London-Tel Aviv
Customers will now benefit from a daily lift of 29 tonnes; representing a net increase of 2,500 tonnes in summer 2016 vs the same time this year, an increase of 72 per cent.
December 2, 2015
By PLA Editor
Air & Cargo Services air cargo Air Cargo Asia air cargo freight Air Forwarding air freight Air Freight Asia Air Freight Logistics air freighter air freighting Air Logistics Asia Air Shipping Asia airlines cargo airways cargo asia cargo news cargo aviation IAG Cargo pharma pharmaceuticals
From March next year, IAG Cargo is replacing its remaining A321 with wide-body B777-200s between London Heathrow and Tel Aviv. The twice daily service will be particularly beneficial to Israel’s fast-growing time and temperature-sensitive pharmaceuticals sector, according to IAG Cargo. Customers will now benefit from a daily lift of 29 tonnes; representing a net increase of 2,500 tonnes in summer 2016 vs the same time this year, an increase of 72 per cent.
Israel is a major manufacturer of pharmaceutical products and its total pharmaceuticals market is expected to grow to US$2.3 billion by 2020. Connecting through IAG Cargo’s London GDP approved Heathrow hub, Israeli drug companies’ benefit from access to 106 Constant Climate approved destinations, including extensive connections to the high-growth pharmaceuticals markets of Latin America.
“Tel Aviv is a thriving business centre and it’s also one of the most important regions for the manufacture of pharmaceuticals. Through the additional capacity delivered by the 777-200, we can now offer manufacturers in the region greater lift, helping them, as they look to grow their businesses,” said Alan Dorling, global head of Pharmaceuticals & Life Sciences at IAG Cargo.